Trials / Completed
CompletedNCT01509391
Keyhole Limpet Hemocyanin in Chronic Hepatitis C
Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - Pilot Study IM1
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In this study the investigators examine the safety and efficacy of Keyhole-limpet-hemocyanin in patients with chronic hepatitis c infection and liver cirrhosis. The investigators hypothesize that administration of keyhole-limpet-hemocyanin reduces the viral load in patients infected with hepatitis c.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | keyhole-limpet hemocyanin | Subcutaneous administration keyhole-limpet hemocyanin |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2012-01-13
- Last updated
- 2012-10-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01509391. Inclusion in this directory is not an endorsement.